logo
  

BioNTech To Acquire Kite's Neoantigen TCR Cell Therapy R&D Platform, Gaithersburg Facility

German biotechnology company BioNTech SE (BNTX) Monday announced that it has entered into a purchase agreement with Kite, a Gilead Company (GILD). Under the deal, BioNTech will acquire Kite's solid tumor neoantigen T cell receptor or TCR R&D platform and clinical manufacturing facility in Gaithersburg, MD. Financial terms of the deal were not disclosed.

In pre-market activity on Nasdaq, BioNTech shares were losing around 2.5 percent to trade at $225.70.

Under the deal terms, Kite will receive a one-time upfront payment from BioNTech to purchase Kite's individualized solid tumor neoantigen TCR discovery platform as well as the Gaithersburg R&D and clinical manufacturing facility.

Kite's new manufacturing facility in Frederick, MD for commercial production of CAR T-cell therapy is not part of the deal.

The acquired Gaithersburg facility will provide production capacity to support clinical trials in the United States. It will complement BioNTech's existing cell therapy manufacturing facility in Idar-Oberstein, Germany.

The facility will support the development of BioNTech's expanding pipeline of novel cell therapies, including cancer product candidates based on its CAR-T Cell amplifying mRNA vaccine (CARVac) and NEOSTIM platforms as well as the newly acquired individualized neoantigen TCR program.

All Kite employees at the Gaithersburg facility will be offered employment with BioNTech prior to the date of closing.

BioNTech also said it plans to further invest in the site including hiring additional personnel.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Twitter has rolled out the tipping feature called "Tips" for everyone around the globe using the microblogging site with more payment options to choose from, including cryptocurrencies such as Bitcoin. This is a new way for people to receive and show support on Twitter with money. The feature is currently available on iOS and will be available on Android over the coming weeks. Amazon.com has launched weekly Max-Your-Vax Sweepstakes to encourage their employees to get vaccinated against COVID-19. The sweepstakes began on August 6, 2021 and ends on October 21, 2021, with six draws during the sweepstakes period for 18 prizes worth nearly $2 million, including cash prizes, new vehicle or cash and vacation plus 40 hours of Paid Time Off. Target Corp. announced its plans to hire 100,000 seasonal team members at its stores across the country for this holiday shopping season, though fewer than previous years. With this, the company aims to invest in more flexible scheduling, training, pay and benefits for its existing team members. In a statement, the company said it is also offering around 5 million more hours to its existing staff.
Follow RTT